| LOXL4 |
Homo sapiens |
|
LOXL4 is differentially expressed in 35 experiments [39 up/42 dn]: 17 organism parts: skeletal muscle [1 up/1 dn], white blood cells [0 up/1 dn], ...; 11 disease states: normal [4 up/1 dn], acute promyelocytic leukemia [1 up/0 dn], ...; 8 cell types, 6 cell lines, 7 compound treatments and 9 other conditions. |
| LOXC, LOXL4, RP11-34A14.4-001, hCG_25154 |
|
Loxl4 (Mus musculus)
(Compare orthologs)
|
|
|
| Lysyl oxidase, Lysyl oxidase, conserved site, Speract/scavenger receptor, Speract/scavenger receptor related |
|
|
| copper ion binding, extracellular region, extracellular space, oxidation reduction, protein-lysine 6-oxidase activity |
|
|
|
Q5W0B3
Q96JB6
|
|
|
|
ENSG00000138131
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Stromal cell
|
Cell type |
|
|
FLAP
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
MK886
|
Compound treatment |
|
|
Skeletal muscle
|
Organism part |
|
|
White blood cells
|
Organism part |
|
|
Caudate nucleus
|
Organism part |
|
|
Skin
|
Organism part |
|
|
Primary gastric tumor
|
Organism part |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Epithelial cell
|
Cell type |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Control
|
Compound treatment |
|
|
Not applicable
|
Histology |
|
|
Cerebellum
|
Organism part |
|
|
Macaca mulatta
|
Organism |
|
|
Superior cervical ganglion
|
Organism part |
|
|
N/a
|
Test result |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
None
|
Gene modification |
|
|
Breast carcinoma
|
Disease state |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
Tumor
|
Organism part |
|
|
Chondrocyte
|
Cell type |
|
|
HTERT/HPVE6/HPVE7/SV40t transf...
|
Gene modification |
|
|
Gastric cancer
|
Disease state |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
Homo sapiens
|
Organism |
|
|
MKN1
|
Cell line |
|
|
A549
|
Cell line |
|
|
HTERT transfection
|
Gene modification |
|
|
Cigarette smoke
|
Growth condition |
|
|
Incubator control
|
Growth condition |
|
|
Beta cell islets
|
Organism part |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Filtered air
|
Compound treatment |
|
|
Gastric adenocarcinoma
|
Disease state |
|
|
Pan troglodytes
|
Organism |
|
|
HTERT/HPVE6/HPVE7/SV40t/hRas t...
|
Gene modification |
|
|
Cartilage
|
Organism part |
|
|
Testis
|
Organism part |
|
|
Seminiferous tubule
|
Organism part |
|
|
Lymph node
|
Organism part |
|
|
Johnsen score count 5: no sper...
|
Histology |
|
|
Obesity
|
Disease state |
|
|
Ischemic cardiomyopathy
|
Disease state |
|
|
Spermatid
|
Cell type |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
Metastatic
|
Disease staging |
|
|
Trigeminal ganglion
|
Organism part |
|
|
Uninfected
|
Infection |
|
|
Vulvar intraepithelial neoplas...
|
Disease state |
|
|
10 ng/ml LPS in media
|
Growth condition |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
Met5A
|
Cell line |
|
|
Bone marrow
|
Organism part |
|
|
Tonsil
|
Organism part |
|
|
Media only
|
Growth condition |
|
|
Fetal brain
|
Organism part |
|
|
Cigarette smoke
|
Compound treatment |
|
|
Cystic change
|
Histology |
|
|
Leydig cell
|
Cell type |
|
|
Geriatric
|
Developmental stage |
|
|
Pediatric
|
Developmental stage |
|
|
Plasmacytoid dendritic cell
|
Cell type |
|
|
|
|
|
Processing time: 0.688 secs.